Procter & Gamble Health declares Q4FY22 result: Procter & Gamble Health announces third quarter results showing 14% growth in net profits. Sales of Rs 262 crores and PAT of Rs 51.2 Crores for quarter ended March 31, 2022 Sales for the quarter up by 23% The Company has delivered total sales of Rs 262 crores for the quarter ended March 31, 2022 vs Rs 214 crores, up by 23% vs year ago. The Profit After Tax (PAT) was Rs 51.2 crores, up by 224% vs year ago. Increase in PAT is driven by higher sales and lower marketing and depreciation charge vs same period last year. Sales for the nine-month period ending March 31, 2022, were Rs 803 crores, vs Rs 710 crores up 13% vs a year ago. PAT for nine-month period is Rs 151 crore Vs Rs 143 crore a year ago, despite high inflationary pressures. Mr. Milind Thatte, Managing Director, P&G; Health India, said, “We have been able to register consistent growth in revenue and earnings in recent quarters. Our strong portfolio of products that address the increasing demand for daily supplementation and a renewed focus on expanded reach and improved productivity continue to form the pillars of our strategy. We will leverage our strengths in medico-marketing, technology and distribution, in order to better serve the consumers and customers who count on us.” “We continue our efforts in promoting consumer education, raising awareness around women’s health and overall health and wellness. This year, we launched ‘Women in Healthcare’ summit as a platform to encourage more women to join the healthcare and pharma sectors. We continue to strengthen and expand our projects under SEHAT, our CSR program that aims at contributing to building a healthier India. Recently, we partnered with Apnalaya, to extend our support to the urban poor and provide care to underprivileged pregnant women, new mothers and newborns,” he added. Result PDF
Pharmaceuticals firm Procter & Gamble Health declares Q3FY22 result: Sales up by 15% for quarter ended December 31, 2021 The company has recorded a total sale of Rs 273 crores for the quarter ended December 31, 2021, vs Rs 238 Crores a year ago, up by 15%. The Profit After Tax (PAT) was Rs 44.8 crores vs Rs 67.9 crores a year ago due to higher investments in marketing initiative to support growth in current year and help of one time reversals in the base period. Sales for the six-month period ending December 31, 2021, were Rs 541 crores, vs Rs 496 Crores a year ago, up by 9%. Profit After Tax for same period was Rs 100.2 Crore vs Rs 127.1 Crore a year ago Milind Thatte, Managing Director, Procter & Gamble Health Limited said, “The Company has delivered sales of Rs 273 Crores in a challenging quarter growing by 15% over year ago on the back of continued demand for our quality and affordable vitamins, minerals, and medicinal products. The pandemic has made consumers overall more cognizant of their health and wellness needs, with a growing demand for trusted brands for themselves and their families as they live in the new normal. Our teams continued to step up on category and brand building efforts through innovative scientific forums, consumer awareness and pharmacy education initiatives. The Company, in association with FOGSI (The Federation of Obstetric and Gynaecological Societies of India), achieved a new GUINNESS WORLD RECORD™ title, for its efforts on creating awareness on Iron Deficiency Anemia. The Company launched ‘P&G; Health Academy’ a new scientific education platform for Doctors, and also initiated a new sustainability initiative for Pharmacies under its flagship CSR program ‘SEHAT’ (meaning Health), among various other initiatives. We are delighted to share that SEHAT recently bagged the prestigious Gold in the ‘Best Public Health Initiative’ category at the India Health and Wellness Awards supported by Niti Aayog. With continued focus on health and safety, the Company also introduced a host of initiatives towards supporting wellness needs of our employees. The Company has made significant progress in its gender diversity efforts recording a 4x increase in the number of women in the sales hierarchy over the last 12 months,” he added. Result PDF